Citi Pharma to list Citi Veterinary Pharma, targets Rs2bn IPO

MG News | March 03, 2026 at 02:31 PM GMT+05:00

0:00

March 03, 2026 (MLN): The Board of Directors of Citi Pharma Limited has approved the initiation of the Initial Public Offering of Citi Pharma's wholly owned subsidiary, Citi Veterinary Pharma Limited.

The Company has been established as a dedicated entity focused towards the manufacturing of Veterinary focused API's and Pharmaceutical products for the consumption of the local market, the company's filing on PSX revealed today.

In this regard, the Board has approved the appointment of K-Trade Securities Limited as the Consultant to Issue with the aim to list the Company at the earliest. The Company plans to raise between Rs1.0bn to Rs2.0bn through the IPO.

This marks a significant milestone for Citi Pharma Limited for increasing it's revenue sources through diversification in a pharma related field. It may also be informed that Citi Pharma plans to generate approx. Rs1.50bn in revenue through trading of veterinary products in FY26.

Copyright Mettis Link News

Related News

BFAGRO achieves 80% completion of egg processing facility

D.G. Khan Cement AA- ratings stable

Name	Price/Vol	%Chg/NChg
KSE100	157,132.10 429.92M	3.39% 5159.10
ALLSHR	93,566.86 763.32M	2.62% 2388.00
KSE30	48,302.97 218.66M	4.27% 1976.50
KMI30	220,798.52 207.58M	4.07% 8628.34
KMIALLSHR	59,988.53 433.51M	2.75% 1606.15
BKTi	46,193.08 61.76M	4.26% 1887.06
OGTi	30,193.10 21.94M	3.73% 1086.31

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	66,835.00	69,740.00 66,530.00	-2645.00 -3.81%
BRENT CRUDE	83.06	83.37 78.38	5.32 6.84%
RICHARDS BAY COAL MONTHLY	99.40	0.00 0.00	-7.85 -7.32%
ROTTERDAM COAL MONTHLY	139.50	139.50 129.00	20.70 17.42%
USD RBD PALM OLEIN	1,083.50	1,083.50 1,083.50	0.00 0.00%
CRUDE OIL - WTI	76.07	76.51 70.41	4.84 6.79%
SUGAR #11 WORLD	14.12	14.15 13.94	0.21 1.51%